The Valley Desk

NCT06579105 · Interventional trial

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.

Overall registry status Completed

Phase 2

Conditions Diabetes Mellitus, Type 2

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov